Alleviare India Logo


IDHIFA (enasidenib) is an inhibitor of isocitrate dehydrogenase-2 (IDH2) enzyme. If you have question, please e-mail Allevaire Indian Team or call Allevaire India on +91-9818274099 (Mr. Kamal Kaushal) for further details.

IDHIFA can cause a condition called differentiation syndrome, which affects blood cells and can be fatal if not treated.

IDHIFA (enasidenib) targets a specific gene mutation called IDH2, which can affect your bone marrow. IDH2 mutation prevents young blood cells from developing into healthy adult blood cells, which can result in symptoms of acute myeloid leukemia.

IDHIFA is used to treat acute myeloid leukemia in adults with an IDH2 mutation.

IDHIFA is used when AML has come back or has not improved with prior treatment.

IDHIFA (Enasidenib)Tablets suppliers in India. Allevaire India Network New Delhi, INDIA.

Alleviare Life sciences Pvt. Ltd. is a consulting pharmaceutical company specialized in providing medicines under Named Patient Program/Manage Access Program. Named Patient Program/ Manage Access Program is a program designed by the government of India and governments of many countries worldwide for patients who have exhausted the treatment options available in their respective countries and are in need of latest medicines that are available in countries of Europe and USA.

The order for IDHIFA (Enasidenib) Tablets will be confirmed only after the receipt of valid prescription of doctor and import permit if applicable.

IDHIFA is indicated for the treatment of adult patients with relapsed or refractory acute myeloid leukemia (AML) with an isocitrate dehydrogenase-2 (IDH2) mutation as detected by an FDA-approved test.

Uses of IDHIFA (Enasidenib)Tablets:

IDHIFA is a prescription medicine used to treat people with acute myeloid leukemia (AML) with an isocitrate dehydrogenase-2 (IDH2) mutation whose disease has come back or has not improved after previous treatment(s). It is not known if IDHIFA is safe and effective in children.

Medicine Name: Idhifa Tablets
Generic Name: Enasidenib
Approval Date: Aug 1, 2017
Company Name: Celgene Corporation

idhifa 100 mg

IDHIFA (Enasidenib) is available.

Get In Touch

    IDHIFA (Enasidenib) Tablets suppliers in India

    ALS helps patients, doctors and hospitals as a facilitator to import prescription medicine brand IDHIFA (Enasidenib) Tablets on prescription and Import License in Patient’s Name only.

    For foreign countries patients, IDHIFA (Enasidenib) Tablets can be made available in Send your inquiry to find IDHIFA (Enasidenib) Tablets in China, Cambodia, Indonesia the Philippines, Singapore, Thailand, Vietnam, Hong Kong. UAE Iraq, Iran, Saudi Arabia, Jordan, Mexico, Argentina, Brazil, Chile, Colombia, Peru, Venezuela. Europe – Romania, Switzerland, Georgia, Turkey, Italy, UK, Ukraine, Azerbaijan, Latvia, Poland, Slovakia. Russia CIS – Armenia, Kazakhstan, Moldova, Tajikistan, Turkmenistan, Uzbekistan, Mongolia, Algeria, Mauritius, Uganda, Zimbabwe. Australia and New Zealand.

    News / Update for IDHIFA (Enasidenib) Tablets

    For IDHIFA (Enasidenib) Tablets Indications And Usage, Dosage And Administration, Dosage Forms And Strengths and Drug Interactions For More Details